The present invention relates to compounds of Formula I,
##STR1##
wherein R1, R2, R3, R4, and n
are as defined, and to pharmaceutically acceptable salts of said compounds. Compounds
of Formula I have activity in agonizing 5HT7 receptors and are useful in treating,
for example, disorders that can be treated by modulating circadian rhythms.
